The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Great call!
People, it's just so obvious Bald Eagle and Lord Top are a) De-Rampers and b) The same person. Just ask yourself, why else would anyone spend so much time putting a negative slant on anything remotely positive that appears on this BB ?
His / Her numerous responses to todays positive RNS is a classic illustraton.
Just ignore, and for goodness sake don't comment. It just gives him / her more opportunity to reply with more rubbish.
'heated, cooling cycle the enervated the nerves in the c0ck'.
typo and 'why is p3nis' a dirty word?
FrankMu, thank you for your response.
If FUM are indeed applying for a patented formulation (possibly a molecule) it doesn't quite agree with the way Ken James described how MED3000 is thought to work, some sort of 'heated, cooling cyscle the enervated the nerves in the *****'....which to a layman would be a mode of action (or a physical process). Since MED3000 is based on a placebo derived formulation it rather begs the question.."what is the active ingredient?"....what is the 'molecule' that is being delivered through the skin barrier by DermaSys?
You do also suggest that the examiner might "ask for more clarification about the mechanisms of action though."...surely that is the mode of action. Which brings us back to the basic question...is MED3000 a physical or a chemical phenomenon?
>>FrankM, thank you for a sensible response. So in your opinion do you think FUM will need to know the mode of action for how MED3000 to get the patent
No, they are most likely applying not for a mode of action but a formulation (and possibly molecule) given the title of the document is "Topical composition". The IPO (the intellectual property office) is not a scientific laboratory and won't carry out any peer review, examiners will just try to see if the patent scope is well define, if if clashes with existing prior art (patents, papers, etc) or not, if it adheres to legal standards (patent language has to be very precise). The examiner might ask for more clarification about the mechanisms of action though. FUM is hopefully verifying she science behind it independently of the patent application outcome
bald eagle thanks for clarifying.certainly not taking issue with you.let us hope matters go better here than with fortacin.first hurdle ema approval,so some time to wait but hopefully the "device"route will prove to be a slightly less arduous road to travel.
theItalian, didn't mean to imply that PE is the same or even similar to ED. Just filling in the gap on the FUM product that I couldn't remember. Please ignore because PET500 is irrelevant to FUM's future...although it is part of the history of course.
Your point on Fortacin is interesting. Sometimes despite the best hopes of 'management' a product just doesn't take off in a region. Whether that is people prefer to stick with what they know, cultural reasons, or simply a lack of marketing budget.
CSD500 was delayed & delayed & delayed....some delay in regulatory approval, then pharma partners messing them about...then the 2 year shelf life fiasco (self inflicted & entirelt FUM's fault IMO)...when it was finally ready it had to battle generic viagra. Perhaps if it was released earlier it would have got some traction...who knows, water under the bridge. But still part of FUM's history of course.
just to clarify for the sake of accuracy,fortacin is actually marketed by the italian company Recordati under licence from regent pacific.
bald eagle the PE market is ,i suspect,significantly different from the ED market.even fortacin which has EMA approval and is marketed by regent pacific in the ED market has found it impossible to gain any traction in europe,although it is attempting to move from prescription authorisation to OTC,in the hope that this may encourage sales.viagra and similar have of course been very successful in the ED marketplace, so one would hope that a product which is suggested to have adventges over viagra etc would also prove popular if regulatory approval can be obtained.no certainty of course and only time will tell.
PET500 is a topical spray that combines our highly efficient DermaSys® AquaFree delivery system with a well-known mild topical anaesthetic. PET500 is licensed to Ansell, one of the world's major sexual health companies, who have worldwide rights to the product and who launched the product in the USA under the name EPIC®. The product is designed to take effect rapidly and to delay male ejaculation, thereby offering enhanced sexual control. Whilst EPIC® was made available in stores throughout the USA, its sales have been modest to the extent that it is no longer stocked by a major US retailer. We believe that the sales performance reflects a lack of promotional activity and we continue to explore how to take the product forwards. [interim results, sept 2015]
I believe that is the last mention of PET500.
"PET500, our innovative spray for enhanced sexual control, which is licensed to Ansell Limited, is progressing through its phased launch and roll out in the USA." [interim results, sept 2012]
I think PET500 was for premature ejaculation...released in Walgreens but soon disappeared.
theItalian, your opinion is as valid as anyone elses and appreciated. Patents are complicated (from the little I know) and it is unlikely many of us (apart from FrankMu of course) have an opinion that isn't biased to some extent. As long as people are aware of some of the more obvious risks.
As I say, I don't know enough about requirements for getting a patent. Fum have got patents for Dermasys before but MED3000 may be different. The mode of action for MED3000 (placebo derived) seems to be somewhat unique. I suppose it depends on the patent application and what feature they are patenting. Based on what Ken James has said the BOD have a theory on how MED3000 works and they are presumably working on verifying that. The patent office will decide if that can be patented.
I'm not sure how much weight potential distribution partners will place on whether MED3000 is patented. Perhaps they are more interested in regulatory approval. Ultimately if FUM do get a product on the shelf then it will be customer demand driven by efficacy of the product that will generate revenues. But I'm not sure pharma companies will see MED3000 as a wonder product demanding a high upfront payment....possibly they will based any deal on sales. Which could mean a rights issue h1 2021 becomes unavoidable.
Several of FUM's products have failed to create a stir with customers...CSD500 the obvious one and there was another (which eludes me). Hopefully MED3000 can actually deliver on the expectations/excitement of 'the management' this time.
well i bet she's glad of all that space in the garden.plenty of room to hide etc.and he clearly doesn't get it does he (actually I'm sure he does) that there is virtually no chance (i emphasise virtually)of any partnering or licensing or coming to any other significant agreement with FUM until they have EMA approval.it just won't happen that way imo.but if they do get approval i am certain there will be very significant interest.its pretty binary really but these small bios almost always are.and as I'm on yesterdays discussions about patents were interesting .far too technical and involved for me to have any meaningful input,but i am conscious that fum have clearly successfully patented previous incarnations of the process/formulation so no reason to suppose they won't here (other of course than bias and agenda).just my OPINION.
Poor mrs top up , patience of a saint , you must be a joy to live with ,,,,,,,,
A very thought provoking point for discussion, bald eagle.
In my view, FUM are "all over the place" and don't really know what they're doing to be honest. For all their efforts to sell the (as yet) unpatented placebo, there are still no takers as FUM now appears to be permanently re-rated as a penny share.
A very badly run company trying to peddle junk sums FUM up for me.
Enjoy the sunshine this weekend but remember not to break the lockdown rules. Fortunately Lady Top Up and I have the luxury of ab extremely large garden.
Toodle pip!
Slap head see you are still causing trouble!!
What a waste of space you are.
This is funny
For FUM to say that Dermasys is patented is a little misleading IMO. All the previous patents (or most) are irrelevant now
Or most . is that a negative with a positive then a negative ,I’m confused
Is it maybe no could well be sort off , well a little bit patent . lmao
Crazy answer if it was that easy for these guys to rub something on it to get an erection. They would not need it , it obvious by the remarkable results it does more than that , they have proven it by the trials . stupid is stupid does omg , there is nothing on the market like this just waffle for waffles sake ,give it a rest , I hope the research doesn’t really cost that much , I’m flabbergasted if we didn’t know you had three heads and some weird festish to try and stir trouble ,I would be very concerned
Really sad your mother must be proud still not acceptable what you said about Coronavirus, karma
FrankM, thank you for a sensible response. So in your opinion do you think FUM will need to know the mode of action for how MED3000 to get the patent. The other MED formulations involved in creating a 'formulation' to optimise the transfer of GTN through the skin barrier. But MED3000 may not involve this process and instead rely on another mechanism (some sort of cooling, heating nerve stimulation has been suggested I believe). So would the new patent possibly give added IP over a formulation?
I suppose the MED3000 patent application could stand or fall on whether FUM can find a genuine unique sscientific reason why MED3000 (placebo derived) works so effectively. A regulator might suggest it's because it's massaged onto a very sensitive region and FUM will have to prove otherwise IMO.
For FUM to say that Dermasys is patented is a little misleading IMO. All the previous patents (or most) are irrelevant now. The real truth is that Dermasys is probably patent pending and the future for FUM & Dermasys relates to the MED3000 patent application.
I expect Futura will have asked Professor Ralph to investigate the MED3000 mode of action...or somebody suitably prestigious. I hope the research doesn't cost too much.
I have some experience with patents but in different areas (hardware), patents are filed as early as possible as that will give you/any company a priority date, then you have a deadline to submit the full document, this gives the applicant time to refine the document, polish details, etc. Then, after a rather long time (it depends on many factors but won't be less than months) the patent is published publicly, this stage hasn't been reached yet for FUM's patent.
Until that happens, we can only speculate about the content, only thing we know so far is the priority date claimed and the title of the patent application. When it becomes published we'll be able to read it, after it's published, there will be examiner searches, reports, substantive examinations, etc before it's granted.
3 heads one brain comes to mind
so much carp , go and play enjoy your school holidays , dont spend all day on here you get to excited
"Now it's groundhog day all over again as it's rinse and repeat time with MED3000. Again nobody is interested - it's a pile of junk only bigged up by FUM's own very well paid directors. Hmmmmm, I wonder why!"
---------------------------------------------------------------------------------------------------------------------------------
NAIL ON THE HEAD!
Very strong sell
It's all smoke and mirrors, bald eagle.
The very purpose of FUM becoming listed was to complete CSD AFTER the deal with SSL so it could raise the necessary capital and become a sleeping partner receiving royalty income.
Once CSD was returned and it was obvious it would then fail, MED "conveniently" became a valuable asset despite having been returned by both RB and GSK. They apparently looked at it and thought it was rubbish. Just like all the "potential partners" in commercial discussions. Nobody was interested and they were proved right as MED failed Phase 3.
Now it's groundhog day all over again as it's rinse and repeat time with MED3000. Again nobody is interested - it's a pile of junk only bigged up by FUM's own very well paid directors. Hmmmmm, I wonder why! The phrase "a fool and his money are easily parted" should be put forward as a prime example for FUM shareholders. Just saying!
Sad to see them losing money like this, but I suppose they deserve it as they've already been stung by the previous MED. Again another phrase springs to mind: "Fool me once, shame on you. Fool me twice, shame on me".
Enjoy the weekend each and every one and TOODLE PIP!
Baldy, I see you're being disingenuous again. This is what I said to you when you first started peddling the "no active ingredients" nonsense:
"In the last RNS it was stated that Med3000 contains alcohol. Ethanol and isopropranol are found as an active ingredient in oral, parenteral, and topical (including inhalational) prescription and nonprescription drug products. Although it is primarily used because of its solvent properties to help solubilize many drugs, it also possesses several concentration-dependent pharmacological actions, including sedative, carminative, cooling, antipyretic, rubefacient, cleansing, and antiseptic properties. Does that sound like alcohol is not an active ingredient? "
Perhaps you'd be polite enough to comment on it this time, though I won't hold my breath.